ERBB2 and breast cancer: Therefore, the integration of nomogram models significantly improved diagnostic accuracy in differentiating HER2-positive from HER2-negative and HER2-low from HER2-zero breast cancer, surpassing the performance of radiologists and highlighting the potential for enhanced clinical decision-making.